Pharmacological Considerations in Hematologic Disorders Quiz

Warfarin is commonly used as an anticoagulant in hematologic disorders.

Vitamin K is essential for the synthesis of clotting factors II, VII, IX, and X.

High fever is NOT a typical symptom of hemophilia.

Iron sulfate is commonly used as a first-line treatment for iron deficiency anemia.

Prednisone is commonly used to treat immune thrombocytopenia (ITP) by inhibiting the breakdown of platelets.

Thrombosis is the primary adverse effect of heparin-induced thrombocytopenia (HIT).

Imatinib is commonly used as a first-line treatment for chronic myeloid leukemia (CML).

Digoxin is NOT commonly used to treat thrombocytopenia.

Hydroxyurea is used to reduce the risk of thrombosis in polycythemia vera.

Thrombopoietin receptor agonists stimulate platelet production.

Daratumumab is a monoclonal antibody used in the treatment of multiple myeloma.

Tranexamic acid is used to inhibit the action of fibrinolysis in patients with hemophilia.

Pancytopenia is typically seen in patients with aplastic anemia.

Frequent infections are NOT a typical symptom of sickle cell anemia.

Hypertension is a common side effect associated with the use of erythropoietin-stimulating agents (ESAs).

von Willebrand factor deficiency is characteristic of von Willebrand disease.

Increased risk of infection is a characteristic feature of myelodysplastic syndromes (MDS).

Epoetin alfa is a recombinant form of human erythropoietin used in the treatment of anemia associated with chronic kidney disease.

The presence of schistocytes in peripheral blood smear is a characteristic feature of hemolytic uremic syndrome (HUS).